ClinicalTrials.Veeva

Menu

The 3D Stent Study

C

CoreAalst

Status

Enrolling

Conditions

Coronary Artery Disease
Percutaneous Coronary Intervention (PCI)

Treatments

Diagnostic Test: 3DStent

Study type

Observational

Funder types

Industry

Identifiers

NCT06898021
CA-1013

Details and patient eligibility

About

The goal of this observational study is to assess the diagnostic performance of 3D Stent to detect stent under-expansion in patients undergoing percutaneous coronary intervention.

The main question it aims to answer is:

The study hypothesis is that 3DStent technology will offer a comparable assessment of stent expansion compared to intravascular imaging.

Enrollment

200 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient presenting with chronic or acute coronary syndromes (ACS) with a clinical indication for PCI guided by IVUS.

Exclusion criteria

  1. Age <18 years
  2. Coronary lesions requiring total stent length > 48 mm.
  3. Body mass index >35 kg/m2
  4. Uncontrolled recurrent ventricular tachycardia
  5. Cardiogenic shock
  6. Unable to provide written informed consent (IC).

Trial design

200 participants in 1 patient group

Patients undergoing PCI
Description:
Patient presenting with chronic or acute coronary syndromes (ACS) with a clinical indication for PCI
Treatment:
Diagnostic Test: 3DStent

Trial contacts and locations

4

Loading...

Central trial contact

Sofie Pardaens

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems